153 results on '"Maseki, Nobuo"'
Search Results
2. Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma
3. Gilteritinib Monotherapy as a Transplant Bridging Option for a Patient with FLT3-Mutated Acute Promyelocytic Leukemia Who Developed a Second Relapse after All-Trans Retinoic Acid + Chemotherapy, Arsenic Trioxide, and High-Dose Cytarabine Therapy
4. Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma
5. An ets-Related Gene, ERG, is Rearranged in Human Myeloid Leukemia with t(16;21) Chromosomal Translocation
6. t(8;21) Breakpoints on Chromosome 21 in Acute Myeloid Leukemia are Clustered within a Limited Region of a Single Gene, AML1
7. Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production
8. Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells
9. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients
10. Significance of lung resistance-related protein in the clinical outcome of acute leukaemic patients with reference to P-glycoprotein
11. The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia
12. Disappearance of AML1-MTG8 (ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission
13. Clonal and non-clonal karyotypically abnormal cells in haemophagocytic lymphohistiocytosis
14. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia
15. AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon
16. Radiotherapy for localized gastric mucosa–associated lymphoid tissue lymphoma: long-term outcomes over 10 years
17. Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemia
18. Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211
19. Phase II/III Study of R-CHOP-21 Versus R-CHOP-14 for Untreated Indolent B-Cell Non-Hodgkin's Lymphoma: JCOG 0203 Trial
20. Phase II/III Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab (R-CHOP) Versus Biweekly CHOP with Rituximab (R-Bi-CHOP) In Untreated Advanced-Stage Indolent B-Cell Lymphoma: Japan Clinical Oncology Group (JCOG) 0203 Trial
21. Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
22. Effects of Extracellular NM23 Protein on In Vitro Survival of Acute Myeloid Leukemia Cells and Normal Peripheral Blood Mononuclear Cells.
23. Clinical and Genetic Characteristics of Japanese Burkitt Lymphomas with or without Leukemic Presentation
24. Practical Utility of the Revised European-American Classification of Lymphoid Neoplasms for Japanese Non-Hodgkin's Lymphomas
25. Correlation of chromosome abnormalities with presence or absence ofWT1 deletions/mutations in Wilms tumor
26. Mixed-lineage leukemia with t(10;11)(p13;q21): An analysis ofAF10-CALM andCALM-AF10 fusion mRNAs and clinical features
27. Disomy 1 with terminal 1 p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants
28. Evaluation by Multivariate Analysis of the Differentiation Inhibitory Factor nm23 as a Prognostic Factor in Acute Myelogenous Leukemia and Application to Other Hematologic Malignancies
29. Hematologic malignancies with the t(10;11)(p13;q21) have the same molecular event and a variety of morphologic or immunologic phenotypes
30. NovelMLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16) (q23;p13) chromosome translocation
31. Inversion of chromosome 11, inv(11)(p15q22), as a recurring chromosomal aberration associated with de novo and secondary myeloid malignancies: Identification of a P1 clone spanning the 11q22 breakpoint
32. Minimal residual disease in acute monocytic leukemia patient with trisomy 11 and partial tandem duplication of MLL
33. EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma
34. An evaluation of REAL classification on malignant lymphomas in Japan.
35. Disappearance of AML1 -MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission
36. There may be two tumor suppressor genes on chromosome arm Ip closely associated with biologically distinct subtypes of neuroblastoma
37. Deletion ofWT1andWIT1Genes and Loss of Heterozygosity on Chromosome 11p in Wilms Tumors in Japan
38. Molecular assignment of a translocation breakpoint in acute myeloid leukemia with t(8;21)
39. Karyotypically unrelated clones in acute leukemias and myelodysplastic syndromes
40. research paper Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
41. Practical Utility of the Revised European-American Classification of Lymphoid Neoplasms for Japanese Non-Hodgkin's Lymphomas.
42. Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor.
43. Mixed-lineage leukemia with t(10;11)(p13;q21): An analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features.
44. Hemophagocytic syndrome complicating T-cell acute lymphoblastic leukemia with a novel t(11;14)(p15;q11) chromosome translocation.
45. Myeloblastoma with an 8;21 chromosome translocation in acute myeloblastic leukemia.
46. Deletion of WT1 and WIT1 Genes and Loss of Heterozygosity on Chromosome 11p in Wilms Tumors in Japan.
47. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16) (q23;p13) chromosome translocation.
48. DNA rearrangement and restriction fragment length polymorphism within the first BCR intron in philadelphia-positive acute leukemia.
49. Junctions of the AML1/MTG8(ETO)Fusion Are Constant in t(8;21) Acute Myeloid Leukemia Detected by Reverse Transcription Polymerase Chain Reaction
50. Consistent Detection of TLS/FUS-ERG Chimeric Transcripts in Acute Myeloid Leukemia With t(16; 21)(p11; q22) and Identification of a Novel Transcript
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.